Back to 
DEUTSCHE BANK AG\
DEUTSCHE BANK AG\
CLDX
Showing 0 of 2 quarters
Position history for DEUTSCHE BANK AG\'s holdings in Celldex Therapeutics, Inc.
As of its Q4 2018 13F, Deutsche Bank held 1,268,191 shares of CLDX (Celldex Therapeutics), worth $250,000.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.